Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when TENX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsTenax Therapeutics holds routine annual meeting, elects seven directors for one-year terms
Filed June 4, 2026 · Period ending June 2, 2026 · ~1 min read
Key Changes
-
low
Shareholders elected seven directors to one-year terms expiring in 2027: June Almenoff, Michael Davidson, Declan Doogan, Christopher Giordano, Robyn Hunter, Gerald Proehl, and Stuart Rich.
Item 5.07 verify on EDGAR → -
low
Cherry Bekaert LLP ratified as independent auditor for 2026 with overwhelming shareholder support (21.3 million votes for, 3,688 against).
Item 5.07 verify on EDGAR →
Summary
Tenax Therapeutics held its 2026 annual stockholder meeting on June 2, 2026, conducting standard corporate governance business. Shareholders elected all seven director nominees to the board for one-year terms, with most receiving strong support of over 17 million votes. Director Michael Davidson received comparatively fewer votes (15.8 million for versus 1.8 million withheld), though still won election comfortably.
This filing represents routine annual meeting business with no material changes to company operations or strategy. The election results show broad shareholder support for the current board composition. Retail investors should watch for the company's proxy statement later this year for details on board composition, executive compensation, and any strategic initiatives the newly elected board will pursue in their upcoming term.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
Tenax held its 2026 annual meeting, electing seven directors and ratifying Cherry Bekaert LLP as auditor for 2026.
Show 1 minor / wording change
Added in current filing · verify on EDGAR →
The Company’s stockholders elected each of the following individuals to the Company’s Board of Directors for a one-year term expiring in 2027, or until his or her successor is duly elected and qualified
Seven directors were elected at the annual meeting on June 2, 2026: June Almenoff, Michael Davidson, Declan Doogan, Christopher T. Giordano, Robyn M. Hunter, Gerald T. Proehl, and Stuart Rich. All received strong support with over 17 million votes for most directors, though Michael Davidson received fewer votes (15.8 million for vs 1.8 million withheld). All directors will serve one-year terms expiring in 2027.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 5, 2026 · How we verify